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In late dialysis, by contrast, the residual creatinine clearance is 2-4 ml per minute, and treatment is begun only after a prolonged period of maintenance on a low protein diet.
LOGISTIC PROBLEMS: COST NOT MATCHED BY URGENCY?
With over 150,000 patients being in the world, these issues must be viewed in the perspective of a continuing disproportion between demand and available facilities. The spectacular improvement in terms of survival, as reflected by a ten years' survival rate of about 50%, combined with a new annual input of many more chronic uremic patients, is tending to swamp the facilities in the countries where dialysis is being carried out. These shortages will certainly be aggravated further by putting patients on dialysis early, at a time when uremia, is not Iifethreatening. This problem has already been pointed out (3) but recently obtained long term results (2) now enable one to quantify this question: 1) The date of starting dialysis is put forward by no more than one to two years. On the average the young and especially hypertensive patients showed a reduction in residual creatinine clearance from 10-12 (the starting point for non-obligatory early dialysis) to less than 5 (the starting point for obligatory late dialysis) in such a period of time. 2) Earlier use of dialysis increases costs by 40-50% over these first years. After 5-6 years, however, the effective cost of the dialysis procedure swings back in favor of early dialysis, because of increased rehabilitation and reduced hospitalization time. Thus, the long-term results indicate that early dialysis cannot be considered a less viable approach on grounds of cost. Of course any dialysis approach, early or late, involves the expenditure of astronomical sums of money -so that in the future new alternatives of treatment. whether technological of clinical, will be needed.
ETHICAL SIDE: TOO EARLY MACHINE-DE-PENDENCY?
Is it ethical to begin dialysis before uremia becomes life-threatening? Clearly some patients could lead a satisfactory life with proper conservative treatment for another year or so, but no longer. On the other hand is it ethical at a time when dialysis facilities are available to put off dialysis if clinical signs of uremia call for it (especially cardiovascular and gastrointestinal symptoms) merely because the residual renal function has not yet fallen to the point were dialysis is obligatory? One cer-tainly knows that the changes of uremia progress if the period of treatment by low protein diets is unduly prolonged; and that late or standard dialysis cannot reverse such changes, which actually worsen with time and frequently increase the risk of both subsequent dialysis and transplantation. Are patients actually informed of these truths about standard dialysis of which the nephrologist is now fully aware?
The implicit social value (4) of long-term dialysis, an ethical no less than an economic yardstick, has been shown to improve if dialysis is begun earlier (2) and according to individual clinical needs rather than to standard biochemical formulae.
CLINICAL SIDE: «PROPHYLACTIC» OR «UN-NECESSARY» DIALYSIS?
The long-term results (59 early and 216 late dialysis patients) confirm the value of early dialysis (2) 1) 10 years survival rate: 88% and 55% in the two groups respectively 2) Hospitalization time for clinical complications: 5 In early dialysis there is no correlation between progressive reduction of renal function and the «degree» of uremia (5) . With time the changes of uremia do not progress substantially, thus making the management of the patients easier and preventing the onset of uremic complications. Furthermore, some other alleged «risks» of dialysis (6) would seem to be attributable not so much to dialysis itself as to inadequate use.
While the advantages of early dialysis are thus confirmed, the mechanisms behind these beneficial effects are largely obscure. When dialysis is begun earlier the residual creatinine clearance tends to decrease more slowly compared with conservative treatment. Whatever the cause (improvement in nutrition, cardiovascular status, and Ca/P metabolism; removal of uremic toxins, cyclical administration of heparin, etc.). Could it be that maintaining a higher residual clearance plays a role in the increased well being conferred by early dialysis? It is difficult to be sure of this, yet considering the wide spectrum of clinical and metabolic alterations in chronic uremia and the improved clinical and metabolic state persisting even after the lower residual creatinine clearance has been reached, it seems likely that other factors are responsible. These include a better preservation of the hormonal equilibrium, perhaps for erythropoietin, vitamin D, testosterone, parathormone, gastrin, and insulin (7) . The maintenance of the effects of testosterone and vitamin D make also playa role.
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Whatever the exact mechanisms may be, early dialysis invariably improves clinical and metabolic rehabilitation both during dialysis and during subsequent transplantation. The reservation that transplantation of patients treated by early dialysis (before residual Ccr reached 3-5 ml/min) might eliminate the beneficial effect of uremic depression of the immunological system, with consequent higher immunological intolerance, is no longer tenable (2) . Some features of both cellular reactivity (DNA and RNA lymphocyte transformation after mytogen stimulation) and graft behaviour (rejections and final outcome) do not differ significantly in early dialysis compared with late dialysis.
While graft survival is unaffected the clinical picture of the patient is unquestionably improved. Some clinical and metabolic findings such as lipid and carbohydrate metabolism, vascular calcifications, etc. may differ significantly in patients transplanted following early rather than standard late dialysis (8) . The patient is better rehabilitated and therefore in a better clinical condition to return to dialysis if that should be necessary.
It is clear that many other problems remain to be solved. Further investigations require a comparison of results from different centers, a better understanding of the results obtained, and a greater insight into some of the mechanisms that may be involved. Meanwhile the long term results of early dialysis confirm its validity from the ethical, economic, and clinical points of view.
